Radiopharm Theranostics Limited
RADX · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $49 | $34 | $27 | $26 |
| - Cash | $29 | $19 | $12 | $27 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $20 | $16 | $15 | -$1 |
| Revenue | $4 | $0 | $0 | $0 |
| % Growth | 1,114.3% | 2.3% | 3,210.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 1.1% | 100% | 100% | 100% |
| EBITDA | -$38 | -$44 | -$31 | -$18 |
| % Margin | -1,050.4% | -14,732.4% | -10,668.6% | -203,412.5% |
| Net Income | -$38 | -$48 | -$35 | -$30 |
| % Margin | -1,055.3% | -16,024.3% | -11,838.6% | -343,550.9% |
| EPS Diluted | -5.28 | -36 | -33 | -29.76 |
| % Growth | 85.3% | -9.1% | -10.9% | – |
| Operating Cash Flow | -$37 | -$23 | -$23 | -$10 |
| Capital Expenditures | $0 | $0 | -$2 | -$28 |
| Free Cash Flow | -$37 | -$23 | -$25 | -$38 |